Characterization of Somatomedin Binding in Human Serum by Ultracentrifugation and Gel Filtration*
- 1 November 1982
- journal article
- research article
- Published by The Endocrine Society in Journal of Clinical Endocrinology & Metabolism
- Vol. 55 (5) , 916-921
- https://doi.org/10.1210/jcem-55-5-916
Abstract
It is known that the somatomedins exist in human serum complexed to specific binding proteins. The existence of unbound somatomedins in serum has never unequivocally been demonstrated. We have characterized the distribution of insulin-like growth factor (IGF) I in different fractions after gel filtration of serum through Sephadex G-200 in neutral buffer. IGF-I was measured by RIA after acid extraction. Seventy-two percent of serum IGF-I was associated with large complexes with an estimated size of about 150,000 daltons and 25% was associated with smaller complexes of about 50,000 daltons. No unbound IGF-I was detected. Ultracentrifugation of 10 ml fresh serum was carried out at 106,000 × g for 17 h, after which the tube was aspirated in 1-ml fractions beginning at the top. IGF-I by RIA in fractions 2 and 3 sedimented with albumin; in fractions 4 to 7, the sedimentation pattern approached that of immunoglobulin G. This shift is consistent with the size distribution of IGF-I complexes demonstrated by gel filtration. The failure to find any significant increase in the concentration of IGF-I relative to albumin in the top 30% of the tube (fractions 1-3) after centrifugation argues against the presence of measurable free IGF-I in these fractions. The ability of upper fractions to bind added [125I]IGF-II proved to closely approximate the binding of the initial serum, indicating little sedimentation of the accessible binding protein. The relative binding of [125I]IGF-II by serum aliquots proved to be markedly concentration dependent. At concentrations above 5% serum, the incremental increase of binding as a function of serum concentration was much reduced. We interpret this to indicate that with dilution there is a dissociation of complexes and an increase in accessible binding sites. This phenomenon may modify tissue delivery of somatomedins in interstitial fluid. The data suggest that in undiluted serum there is no significant concentration of free somatomedins but at the dilution of serum that exists in the interstitial fluid, dissociation of bound somatomedins may be facilitated.Keywords
This publication has 13 references indexed in Scilit:
- Plasma Somatomedin-Binding Proteins in Hypopituitarism: Changes during Growth Hormone Therapy*Journal of Clinical Endocrinology & Metabolism, 1981
- Purification and characterization of multiplication‐stimulating activity (MSA) carrier proteinJournal of Supramolecular Structure and Cellular Biochemistry, 1981
- Inhibition of Access of Bound Somatomedin to Membrane Receptor and Immunobinding Sites: A Comparison of Radioreceptor and Radioimmunoassay of Somatomedin in Native and Acid-Ethanol-Extracted Serum*Journal of Clinical Endocrinology & Metabolism, 1980
- The Somatomedin C Binding Protein: Evidence for a Heterologous Subunit Structure*Journal of Clinical Endocrinology & Metabolism, 1980
- Inhibition of the Action of Nonsuppressible Insulin-Like Activity on Isolated Rat Fat Cells by Binding to its Carrier ProteinJournal of Clinical Investigation, 1979
- Immunoreactive Somatomedin A in Human Serum*Journal of Clinical Endocrinology & Metabolism, 1979
- Insulin‐Like Growth Factors I and II: Some Biological Actions and Receptor Binding Characteristics of Two Purified Constituents of Nonsuppressible Insulin‐Like Activity of Human SerumEuropean Journal of Biochemistry, 1978
- NSILA-carrier protein abolishes the action of nonsuppressible insulin-like activity (NSILA-S) on perfused rat heartDiabetologia, 1978
- Demonstration of Specific Plasma Protein Binding Sites For SomatomedinJournal of Clinical Endocrinology & Metabolism, 1977
- Size Heterogeneity of Human Serum Somatomedin12Journal of Clinical Endocrinology & Metabolism, 1976